This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. shed 5.1% to $6.69 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.4% to 23,275.92 and Dow Jones Industrial Average falling 0.9% to 47,289.33.
The stock's fall snapped a five-day winning streak.
Novavax Inc. closed 42.1% below its 52-week high of $11.55, which the company reached on January 7th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.8% to $205.34, Pfizer Inc. fell 1.8% to $25.27, and Merck & Co. Inc. fell 2.86% to $101.83.
Trading volume totaled 2.7 million, compared to the 50-day average of 4.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
December 01, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.